The weed wire

The Canadian extractor says Germany-based Stada will forge the path ahead for big pharma to commercialize medical cannabis

If passed, it will mark the third time the House has approved the SAFE Banking Act legislation

As industry players await full regulations, the US federal agency continues to slowly open up the CBD market

Famed adult magazine teams up with social justice groups to call for legalization

Psychedelic mushrooms will be grown for research purposes

If five states vote green in November, New Frontier Data estimates US$35 billion in legal weed sales by 2025

Ontario extractor inks fourth global contract this month to make up for sinking Canadian revenues

Edmonton-based producer falls from top spot in Canadian recretional cannabis market

Experts say election-year politics played a role in Democrats punting the historic House vote until after the Nov. 3 election

The company is expanding from its dominant Florida position with two acquisitions in Pa.'s promising market

Sales in the country's largest province have skyrocketed 47% since May

The new hub will focus on the rapidly advancing field by adding unique public education and spiritual components

Fire & Flower is set to be dethroned by High Tide as Canada's top pot shop operator as sales continue to climb across the country

The Canadian Health Food Association says regulating CBD within the Cannabis Act hurts first-mover advantages and drives consumers to the illicit market

Without meaningful opening of the economy, the company projects further flat to modest revenue growth

Funding goes disproportionately towards researching vice over virtue, study shows

Because more people are using cannabis to treat pain, researchers wanted to study if use leads to the same threshold-reduction as opioids

Canadian weed titan hopes Stewart's celebrity power will catapult it above the 3,000 brands in the US CBD space

Kurt Schmidt brings over 30 years of executive chops from global brands like Nestlé, Gerber and Kraft

Funding will go towards commercialization of rare cannabinoids produced from yeast

Emerald Health Therapeutics sells its 41.3% stake in the previous joint venture

Only 265 pardons have been granted through Bill C-93 so far, a figure that's been called 'shameful'

'The entire amount will be remitted to the government and reinvested primarily in cannabis research and prevention'

Company says it will disclose layoffs in upcoming earnings call

With one store open per 97,000 people, the provincial government says its ramping up authorizations

Cannabigerol (CBG) shows higher efficacy in one-third of current CBD topical applications, company says

The Ontario-based extractor signed two deals with Danish suppliers as the European market continues to expand

Seattle-based data firm eyes 6 US states set to vote on cannabis ballots in November

Its proprietary ALID-10 and ALID-11 compounds are in Phase 1 clinical trials

The state's biggest weed firm says it's ready to lead the segment and meet the demand of Florida's 400,000 patients

Tetra Bio-Pharma's results relate to other findings that high doses of CBD can cause toxicity in the liver when ingested

Initial lab results showed Ikänik's registered genetics inhibited the replication cycle of Covid-19 by 62.5%

Product format part of 3-year manufacturing agreement with Avicanna

A partnership with cannabis firm Khiron will teach physicians how to prescribe for pain, anxiety, cancer and epilepsy